Biologic Therapies III

 

Biologic Therapies III

Biologic agents have become an important part of the overall
therapeutic strategies for clinicians caring for patients with
rheumatic and inflammatory diseases. Patients who are
candidates for biologic therapies often present with other comorbidities, including infections, malignancies, cardiovascular disease, and autoimmune diseases. Understanding and incorporating these comorbidities into the management approach is important for clinicians when prescribing biologics in these special populations.

    Read More >>

Print this Content

Case-based Lessons
Biologics III RA and Granulomatous Infection
Estimated Time: 15 minutes
Release Date: April 21, 2010
Type: Case-Based Lesson 		Technical Requirements: Adobe Flash Player
Expiration Date: April 21, 2012
Specialties: Pulmonology, Rheumatology / Immunology
Biologics III Vasculitis and Biologics: A Continuing Conundrum
Estimated Time: 15 minutes
Release Date: April 21, 2010
Type: Case-Based Lesson 		Technical Requirements: Adobe Flash Player
Expiration Date: April 21, 2012
Specialties: Rheumatology / Immunology

Series Objectives

  1. Review and describe recent advances in basic immunology including B cell biology, cytokine biology, cell trafficking, and tolerance.
  2. Assess risks and mechanisms and prevention strategies for infectious complications attendant to biologic therapies.
  3. Describe the mechanisms of action, indications, and toxicity of newly approved agents as well as those in late development.
  4. Assess prevalence and risk of rare complications associated with agents in this class including hematologic, immunologic, cardiovascular, neurologic.
  5. Manage highly complex patient scenarios with biologics and compare their management decisions with global experts.

Target Audience

This Series is directed to rheumatologists, gastroenterologists, dermatologists, pulmonologists, internal medicine physicians, nurse practitioners, physician assistants, and other healthcare professionals interested in or using biologic therapeutics in autoimmune and inflammatory disorders.

Activity Director

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic & Rheumatologic Institute
Cleveland Clinic

  

Accreditation

These activities have been approved for AMA PRA Category 1 Credit™

Planning Committee

Edward Keystone, MD, FRCPC
Professor of Medicine
University of Toronto
Director, Rebecca MacDonald Centre
  for Arthritis & Autoimmune Disease
Mount Sinai Hospital
Toronto, Ontario, Canada

Elizabeth Kirchner, CNP
Department of Rheumatic &
Immunologic Diseases
Orthopaedic & Rheumatologic Institute
Cleveland Clinic

Christopher T. Ritchlin, MD
Associate Professor of Medicine
Allergy, Immunology
Rheumatology Unit
University of Rochester Medical Center
Rochester, NY

 


E. William St. Clair, MD
Professor of Medicine & Immunology
Department of Medicine
Division of Rheumatology & Immunology
Duke University Medical Center
Durham, NC

Nizar N. Zein, MD
Associate Professor of Medicine
Cleveland Clinic Lerner College of
Medicine of Case Western
Reserve University
Chief, Section of Hepatobiliary Diseases
Department of Gastroenterology & Hepatology
Digestive Disease Institute
Cleveland Clinic